Literature DB >> 22734387

[Preliminary study on the visualization of ultrasound-guided acupotomy manipulation].

Yu Ding1, Yue-Xiang Wang, Xian Shi.   

Abstract

OBJECTIVE: To evaluate the feasibility and safety of visualized acupotomy.
METHODS: The ultrasound-guided acupotomy was applied to 52 cases of soft tissue injury and osteoarthropathy. Visual Analog Scale (VAS) was adopted. VAS score was observed before and after treatment. The modified knee joint scale of hospital for special surgery (HSS) and Constant-Murley shoulder function scale were used to assess the joint function of patients with arthritis of knee and periarthritis of shoulder.
RESULTS: After treatment, VAS score was improved apparently as compared with that before treatment (6.560 +/- 0.893 vs 1.058 +/- 0.857, P < 0.05). The curative rate after one treatment was 48.1% (25/52) and the total effective rate was 98.1% (51/52). After treatment, HSS and Constant-Murley scores were improved apparently (both P < 0.05). In follow-up, the complications were not discovered, such as infection and nerve injury.
CONCLUSION: The ultrasound-guided acupotomy is the safe and effective therapy for soft tissue injury and osteoarthropathy and this therapy deserves to be promoted in clinical practice.

Entities:  

Mesh:

Year:  2012        PMID: 22734387

Source DB:  PubMed          Journal:  Zhongguo Zhen Jiu        ISSN: 0255-2930


  2 in total

Review 1.  Acupotomy Therapy for Shoulder Adhesive Capsulitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Jianyu You; Fengyun Yang; Naigang Liu; Nana Tang; Ting Fang; Fushui Liu; Zhongyong Liu; Hongwu Xie
Journal:  Evid Based Complement Alternat Med       Date:  2019-12-13       Impact factor: 2.629

2.  Ultrasound-Guided Percutaneous Release Procedures in the Lumbar Ligamentum Flavum by Acupotomy: A Cadaveric study.

Authors:  Xinyue Zhu; Yifeng Shen; Zixiang Liu; Peiliang Gu; Shiliang Li; Weiguang Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-23       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.